Role of Anti-PD-1 Antibodies in Advanced Melanoma: The Era of Immunotherapy

Advanced melanoma is an aggressive skin cancer characterized by poor survival rates and response to cytotoxic chemotherapy. Immune checkpoint inhibitors are novel agents capable of utilizing one’s own immune system to bring about the tumor destruction. Nivolumab and pembrolizumab are fully humanized...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahni, Sakshi, Valecha, Gautam, Sahni, Ankit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372252/
https://www.ncbi.nlm.nih.gov/pubmed/30788189
http://dx.doi.org/10.7759/cureus.3700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372252/
https://www.ncbi.nlm.nih.gov/pubmed/30788189
http://dx.doi.org/10.7759/cureus.3700

Ejemplares similares